CHIP has evolved from a hematologic curiosity to a clinically meaningful driver of cardiometabolic risk, with meta-analyses linking it to higher all-cause mortality and increased coronary, HF, and stroke events, particularly with larger clone sizes. The gene discussed is STUB1; the disease is hydrops fetalis.